Haemonetics Corp
- Last sale
- Nov 12, 2026 · +1.72%
- Market cap
- $5.59B
- 45.54M shares
- Filings
- 1,033
Q2 2027−2.0% FY26 yoy
Q2 2027−42.0% FY26 yoy
Q2 2027−29.3% FY26 yoy
Q2 2027derived+82.8% FY26 yoy
Q2 2027−38.1% FY26 yoy
Q2 2027−20.0% FY26 yoy
- $5.59B
- 53.8×
- 4.0×
- 6.2×
- 5.34%
- —
Twelve months to Sep 26, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2026 | 2026-03-28 | $1,334,027,000 | reported | |
| FY 2025 | 2025-03-29 | $1,360,824,000 | reported | |
| FY 2024 | 2024-03-30 | $1,309,055,000 | reported | |
| FY 2023 | 2023-04-01 | $1,168,660,000 | reported | |
| FY 2022 | 2022-04-02 | $993,196,000 | reported | |
| FY 2021 | 2021-04-03 | $870,463,000 | reported | |
| FY 2020 | 2020-03-28 | $988,479,000 | reported | |
| FY 2019 | 2019-03-30 | $967,579,000 | reported | |
| FY 2018 | 2018-03-31 | $903,923,000 | reported | |
| FY 2017 | 2017-04-01 | $886,116,000 | reported | |
| FY 2016 | 2016-04-02 | $908,832,000 | reported | |
| FY 2015 | 2015-03-28 | $910,373,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2026 | — | $175.00M | $175.00M | — | 45.45M sh | −5.4% | 67.2% |
| FY2025 | — | $225.00M | $225.00M | — | 48.04M sh | −5.5% | 158.0% |
| FY2024 | — | $0.00 | $0.00 | — | 50.84M sh | +0.6% | 0.0% |
| FY2023 | — | $75.00M | $75.00M | — | 50.54M sh | −1.4% | 91.8% |
| FY2022 | — | $0.00 | $0.00 | — | 51.28M sh | +0.6% | 0.0% |
Segments
LineFY2026ShareChange
Hospital$588.30M44%+4.3%
Plasma$524.46M39%−2.0%
Blood Center$221.27M17%−15.3%
Total$1.33B
Surgical & medical instruments & apparatus
Haemonetics Corp is the 19th largest of the 143 covered companies the SEC files under this code, by revenue. SIC 3841
CompanyRevenueGrowthNet marginMarket cap
TFXTeleflex Inc$2.0B17.2%45.4%$6.1BIARTIntegra Lifesciences Holdings Corp$1.6B1.5%31.6%$1.1BMMSIMerit Medical Systems Inc$1.5B11.8%8.5%$5.2BPENPenumbra Inc$1.4B17.5%12.7%$12.6B
HAEHaemonetics Corp (this company)$1.3B2.0%7.3%$5.6B
EMBCEmbecta Corp.$1.1B3.8%8.8%$364.0MTNDMTandem Diabetes Care Inc$1.0B7.9%20.2%$1.2BINSPInspire Medical Systems, Inc.$912.0M13.6%15.9%$1.8BOFIXOrthofix Medical Inc.$822.3M2.9%11.2%$283.1MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Haemonetics Corp · CIK 313143 · Engraved from SEC EDGAR